These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB. Garrison JB; Samuel T; Reed JC Oncogene; 2009 Apr; 28(13):1584-93. PubMed ID: 19234489 [TBL] [Abstract][Full Text] [Related]
24. Molecular pathways: targeting MALT1 paracaspase activity in lymphoma. Fontán L; Melnick A Clin Cancer Res; 2013 Dec; 19(24):6662-8. PubMed ID: 24004675 [TBL] [Abstract][Full Text] [Related]
25. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma. Hosokawa Y Apoptosis; 2005 Jan; 10(1):25-34. PubMed ID: 15711920 [TBL] [Abstract][Full Text] [Related]
26. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation. Che T; You Y; Wang D; Tanner MJ; Dixit VM; Lin X J Biol Chem; 2004 Apr; 279(16):15870-6. PubMed ID: 14754896 [TBL] [Abstract][Full Text] [Related]
27. The protease activity of the paracaspase MALT1 is controlled by monoubiquitination. Pelzer C; Cabalzar K; Wolf A; Gonzalez M; Lenz G; Thome M Nat Immunol; 2013 Apr; 14(4):337-45. PubMed ID: 23416615 [TBL] [Abstract][Full Text] [Related]
28. MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-κB signaling. Elton L; Carpentier I; Staal J; Driege Y; Haegman M; Beyaert R FEBS J; 2016 Feb; 283(3):403-12. PubMed ID: 26573773 [TBL] [Abstract][Full Text] [Related]
29. Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity. Jaworski M; Marsland BJ; Gehrig J; Held W; Favre S; Luther SA; Perroud M; Golshayan D; Gaide O; Thome M EMBO J; 2014 Dec; 33(23):2765-81. PubMed ID: 25319413 [TBL] [Abstract][Full Text] [Related]
30. MALT1 contains nuclear export signals and regulates cytoplasmic localization of BCL10. Nakagawa M; Hosokawa Y; Yonezumi M; Izumiyama K; Suzuki R; Tsuzuki S; Asaka M; Seto M Blood; 2005 Dec; 106(13):4210-6. PubMed ID: 16123224 [TBL] [Abstract][Full Text] [Related]
31. The origin and targeting of mucosa-associated lymphoid tissue lymphomas. Martinez-Climent JA Curr Opin Hematol; 2014 Jul; 21(4):309-19. PubMed ID: 24867288 [TBL] [Abstract][Full Text] [Related]
32. MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. Sanchez-Izquierdo D; Buchonnet G; Siebert R; Gascoyne RD; Climent J; Karran L; Marin M; Blesa D; Horsman D; Rosenwald A; Staudt LM; Albertson DG; Du MQ; Ye H; Marynen P; Garcia-Conde J; Pinkel D; Dyer MJ; Martinez-Climent JA Blood; 2003 Jun; 101(11):4539-46. PubMed ID: 12560219 [TBL] [Abstract][Full Text] [Related]
33. Regulation of NF-κB signaling by caspases and MALT1 paracaspase. Staal J; Bekaert T; Beyaert R Cell Res; 2011 Jan; 21(1):40-54. PubMed ID: 21119681 [TBL] [Abstract][Full Text] [Related]
34. Detection of MALT1 gene rearrangements in BAL fluid cells for the diagnosis of pulmonary mucosa-associated lymphoid tissue lymphoma. Kido T; Yatera K; Noguchi S; Sakurai Y; Nagata S; Kozaki M; Tokuyama S; Ogoshi T; Kawanami T; Yoshii C; Mukae H Chest; 2012 Jan; 141(1):176-182. PubMed ID: 21757570 [TBL] [Abstract][Full Text] [Related]